This Article Full Text Full Text (PDF) All Versions of this Article: 40/3/827    most recent STROKEAHA.108.528034v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Barreto, A. D. Articles by Savitz, S. I. Search for Related Content PubMed PubMed Citation Articles by Barreto, A. D. Articles by Savitz, S. I. Pubmed/NCBI databases Substance via MeSH Medline Plus Health Information Stroke Related Collections Acute Cerebral Infarction Thrombolysis

(Stroke. 2009;40:827.)
© 2009 American Heart Association, Inc.

Original Contributions

Thrombolytic Therapy for Patients Who Wake-Up With Stroke

Andrew D. Barreto, MD; Sheryl Martin-Schild, MD, PhD; Hen Hallevi, MD; Miriam M. Morales, BS; Anitha T. Abraham, MD; Nicole R. Gonzales, MD; Kachi Illoh, MD, MPH; James C. Grotta, MD Sean I. Savitz, MD

From the Stroke Division, Department of Neurology, University of Texas-Houston Medical School, Houston, Tex.

Correspondence to Andrew D. Barreto, MD, Department of Neurology, Stroke Division, University of Texas-Houston Health Science Center, 6431 Fannin Street MSB 7.124, Houston, TX 77030. E-mail andrew.d.barreto{at}uth.tmc.edu; or Sean I. Savitz, Department of Neurology, Stroke Division, University of Texas-Houston Health Science Center, 6431 Fannin Street, MSB 7.125, Houston, TX 77030. E-mail sean.i.savitz@uth.tmc.edu

Background and Purpose— Approximately 25% of ischemic stroke patients awaken with their deficits. The last-seen-normal time is defined as the time the patient went to sleep, which places these patients outside the window for thrombolysis. The purpose of this study was to describe our center’s experience with off-label, compassionate thrombolysis for wake-up stroke (WUS) patients.

Methods— A retrospective review of our database identified 3 groups of ischemic stroke patients: (1) WUS treated with thrombolysis; (2) nontreated WUS; and (3) 0- to 3-hour intravenous tissue plasminogen activator-treated patients. Safety and clinical outcome measures were symptomatic intracerebral hemorrhage, excellent outcome (discharge modified Rankin score, 0–1), favorable outcome (modified Rankin score, 0–2), and mortality. Outcome measures were controlled for baseline NIHSS using logistic regression.

Results— Forty-six thrombolysed and 34 nonthrombolysed WUS patients were identified. Sixty-one percent (28/46) of the treated WUS patients underwent intravenous thrombolysis alone whereas 30% (14/46) were given only intra-arterial thrombolysis. Four patients received both intravenous and intra-arterial thrombolysis (9%). Two symptomatic intracerebral hemorrhages occurred in treated WUS (4.3%). Controlling for NIHSS imbalance, treated WUS had higher rates of excellent (14% vs 6%; P=0.06) and favorable outcome (28% vs 13%; P=0.006), but higher mortality (15% vs 0%) compared to nontreated WUS. A second comparison controlling for baseline NIHSS between treated WUS and 174 intravenous tissue plasminogen activator patients treated within 3 hours of symptoms showed no significant differences in safety and clinical outcomes.

Conclusion— Thrombolysis may be safe in WUS patients. Our center’s experience supports considering a prospective, randomized trial to assess the safety and outcome of thrombolysis for this specific patient population.

Key Words: awakening • ischemic • sleep • stroke • thrombolysis

This article has been cited by other articles:

				A. N. Gonzalez-Hernandez, O. Fabre-Pi, J. C. Lopez-Fernandez, and S. Diaz-Nicolas Intravenous Tissue Plasminogen Activator Thrombolysis in Patients With Diabetes Mellitus and Previous Stroke Stroke, December 1, 2009; 40(12): e707 - e707. [Full Text] [PDF]

				S. K. Natarajan, K. V. Snyder, A. H. Siddiqui, C. C. Ionita, L. N. Hopkins, and E. I. Levy Safety and Effectiveness of Endovascular Therapy After 8 Hours of Acute Ischemic Stroke Onset and Wake-Up Strokes Stroke, October 1, 2009; 40(10): 3269 - 3274. [Abstract] [Full Text] [PDF]